
Covid-19: As lab execs sell shares worth millions, questions arise
15-11-2020 09:25 Executives at several US laboratories developing Covid-19 vaccines have recently pocketed millions of dollars by selling shares in their companies – raising questions about the propriety of such a move in the midst of a global health crisis.